BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 24992599)

  • 1. MicroRNA-122 triggers mesenchymal-epithelial transition and suppresses hepatocellular carcinoma cell motility and invasion by targeting RhoA.
    Wang SC; Lin XL; Li J; Zhang TT; Wang HY; Shi JW; Yang S; Zhao WT; Xie RY; Wei F; Qin YJ; Chen L; Yang J; Yao KT; Xiao D
    PLoS One; 2014; 9(7):e101330. PubMed ID: 24992599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-214-5p Inhibits the Invasion and Migration of Hepatocellular Carcinoma Cells by Targeting Wiskott-Aldrich Syndrome Like.
    Li H; Wang H; Ren Z
    Cell Physiol Biochem; 2018; 46(2):757-764. PubMed ID: 29621773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN.
    Zhang QY; Men CJ; Ding XW
    J Cell Biochem; 2019 Sep; 120(9):14885-14898. PubMed ID: 31044454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of hepatocyte nuclear factor 4alpha in metastatic tumor formation of hepatocellular carcinoma and its close relationship with the mesenchymal-epithelial transition markers.
    Yao D; Peng S; Dai C
    BMC Cancer; 2013 Sep; 13():432. PubMed ID: 24059685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y; He X
    Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
    Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
    Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling.
    Zhang JP; Zeng C; Xu L; Gong J; Fang JH; Zhuang SM
    Oncogene; 2014 Jul; 33(31):4069-76. PubMed ID: 24013226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-19 triggers epithelial-mesenchymal transition of lung cancer cells accompanied by growth inhibition.
    Li J; Yang S; Yan W; Yang J; Qin YJ; Lin XL; Xie RY; Wang SC; Jin W; Gao F; Shi JW; Zhao WT; Jia JS; Shen HF; Ke JR; Liu B; Zhao YQ; Huang WH; Yao KT; Li DJ; Xiao D
    Lab Invest; 2015 Sep; 95(9):1056-70. PubMed ID: 26098000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G; Lin Y; Zhang H; Wu D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.
    Chen JS; Li HS; Huang JQ; Dong SH; Huang ZJ; Yi W; Zhan GF; Feng JT; Sun JC; Huang XH
    Cancer Lett; 2016 May; 375(1):73-83. PubMed ID: 26944318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-153 inhibits epithelial-to-mesenchymal transition in hepatocellular carcinoma by targeting Snail.
    Xia W; Ma X; Li X; Dong H; Yi J; Zeng W; Yang Z
    Oncol Rep; 2015 Aug; 34(2):655-62. PubMed ID: 26035427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of miR-99b in mediating hepatocellular carcinoma invasion and migration.
    Liu CJ; Yang JH; Huang FZ; Yang JH; Liu CP; Mao XH; Yi WM; Shen XB; Peng C; Chen MF; Jiang B; Wu JS
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2273-2281. PubMed ID: 29762829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-1277 Inhibits Proliferation and Migration of Hepatocellular Carcinoma HepG2 Cells by Targeting and Suppressing BMP4 Expression and Reflects the Significant Indicative Role in Hepatocellular Carcinoma Pathology and Diagnosis After Magnetic Resonance Imaging Assessment.
    Cao X; Xu L; Liu Q; Yang L; Li N; Li X
    Oncol Res; 2019 Feb; 27(3):301-309. PubMed ID: 29562958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y; Wang J; Han J; Luo D; Sun Z
    Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
    Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C.
    Tao J; Liu Z; Wang Y; Wang L; Yao B; Li Q; Wang C; Tu K; Liu Q
    Biomed Pharmacother; 2017 Sep; 93():420-428. PubMed ID: 28666208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ECM1 promotes migration and invasion of hepatocellular carcinoma by inducing epithelial-mesenchymal transition.
    Chen H; Jia W; Li J
    World J Surg Oncol; 2016 Jul; 14(1):195. PubMed ID: 27460906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BVES inhibition triggers epithelial-mesenchymal transition in human hepatocellular carcinoma.
    Han P; Fu Y; Luo M; He J; Liu J; Liao J; Tian D; Yan W
    Dig Dis Sci; 2014 May; 59(5):992-1000. PubMed ID: 24442236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis.
    Wong CM; Wei L; Au SL; Fan DN; Zhou Y; Tsang FH; Law CT; Lee JM; He X; Shi J; Wong CC; Ng IO
    Oncotarget; 2015 May; 6(15):13658-70. PubMed ID: 25909223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.